Keragon, a Boston, MA-based AI-powered HIPAA-compliant automation platform for healthcare, has raised $7.5 million in seed funding.
Investors
The oversubscribed round was led by Upfront Ventures, with continued support from early investors Afore Capital, Focal, and 25m Health. This latest funding brings Keragon’s total raised to $10.5 million.
Upfront Ventures is an early-stage venture capital firm based in Los Angeles, investing in technology startups from seed to growth stages across various industries both nationally and globally.
Keragon Use of Funds
The company will use the funding to accelerate AI automation and expand its team, with a focus on software engineering and customer success.
About Keragon
Keragon provides an AI-powered automation platform that enables healthcare professionals to easily connect over 300 popular software and build HIPAA-compliant workflows and automation—without any coding. The platfrom integrates healthcare software tools, including EHRs, CRMs, scheduling platforms, patient intake tools, referral management systems, AI medical scribes, and more. Keragon serves a diverse range of healthcare organizations, from solo practitioners and multi-location clinics to digital health companies and hospitals.
Funding Details
Company: Keragon Inc.
Raised: $7.5M
Round: Seed
Funding Date: February 2025
Lead Investor: Upfront Ventures
Additional Investors: Afore Capital, Focal, 25m Health
Company Website: https://www.keragon.com/
Software Category: Healthcare Workflow Automation
Source: https://www.keragon.com/blog/keragon-ai-powered-healthcare-automation-platform-secured-7-5m-seed-round